—
Your people are your company’s most valuable asset, and their health quietly shapes performance, energy and retention in ways that compound over time. Yet most organisations still only act once something has already gone wrong.
That is starting to change at companies like YEARS, a Berlin-based preventive medicine clinic that is building physician-led health assessment into the fabric of how forward-thinking organisations think about their people.
YEARS works with companies to offer structured health programmes spanning cardiovascular diagnostics, metabolic panels, VOâ‚‚ max testing, and whole-body MRI, all in a single day, all reviewed by a specialist physician who translates the data into a personal prevention plan. For companies that want to move beyond generic health benefits and actually understand where their people stand, the conversation is increasingly starting here.
The Business Case Nobody Talks About at the Board Level
For decades, corporate health was treated as a human resources line item: standard insurance, maybe a gym membership, a meditation app added during a rebrand.
The thinking was transactional. Provide coverage, and the problem is managed.
That model is breaking down, and the data explains why.
Productivity losses linked to absenteeism and presenteeism from chronic illness cost U.S. employers approximately $2,945 per employee per year, according to Kaiser Permanente. But the bigger number is one that does not show up in most absence reports. Research from RAND Europe and Vitality’s 2026 Healthiest Workplace study found that U.S. workers lose an average of 54 productive days per year to presenteeism, the phenomenon of people showing up to work but functioning well below capacity because of untreated or undetected health issues.
A 2024 study from the University of South Florida added a further layer: employees who frequently work through illness experience cumulative health deterioration, slower recovery times and a greater likelihood of leaving their organisation entirely. The short-term gain of having someone at their desk is overwhelmed by long-term costs that are invisible until they are too large to ignore.
Absenteeism – the metric most HR dashboards track – accounts for roughly one in seven of the days lost to poor health. The other six are happening right there at workstations, in meetings, on calls.
An aging workforce makes this more urgent. As people stay productive longer, companies need to keep their teams healthy, energised and capable, not just employed. That requires a different approach than offering the same health benefits package designed for a different era.
And for executive teams, the calculus is even sharper. The loss of a CEO or key leader to a serious medical condition, one that might have been detected and addressed years earlier, carries financial and operational consequences that far exceed anything a standard insurance policy covers. Executive health is a business continuity issue. Most boards do not treat it as one.
Where Traditional Wellness Programmes Fall Short
Gym memberships and meditation apps have their place. They signal a culture of care, and for some employees, they make a genuine difference. But they rarely connect to the things that actually drive long-term health risk. Cardiovascular function. Metabolic health. Early-stage disease indicators that produce no symptoms until they are much harder to treat.
The most effective prevention is not generic. It is personalised, physician-led, and built on actual diagnostic data. It answers questions like: What is this person’s actual cardiovascular risk? Where does their metabolic health stand? Are there indicators developing now that we can act on in the next 12 months, not the next five years?
That level of depth requires more than an app. It requires a medical infrastructure that most HR teams were never set up to build. Which is why the companies getting this right are increasingly turning to specialist providers.
YEARS operates on this principle. The clinic’s three-tier programme structure (Core, Evolve, and Ultimate) is designed specifically for organisations that want to move beyond wellness language into actual prevention. Core offers 87 biomarkers and 25 functional examinations in a single day. Evolve adds whole-body MRI and multi-cancer liquid biopsy screening, expanding the biomarker panel to 120. Ultimate goes to 230 biomarkers, full genomic sequencing, epigenetic age measurement, and microbiome analysis.
The point is that every marker sits in context. A low VOâ‚‚ max has many possible causes: training status, iron deficiency, thyroid dysfunction, a cardiac problem, restricted lung function. If you only measure the VOâ‚‚ max you know the number. If you have ferritin, TSH, hsCRP and the echocardiography at the same time, you have much more information to see potential causes. And you often know what to act on.
That is the difference between a data dump and a prevention strategy.
What Modern Corporate Health Benefits Actually Look Like
The shift happening in forward-thinking companies is from “wellness” to “prevention”. The difference is significant.
Wellness tends to be aspirational: take better care of yourself, and things will improve. Prevention is diagnostic: measure where people actually stand, identify the real risks, and act on them with medical precision.
At YEARS, this distinction is central. The clinic’s corporate programmes are built around a single diagnostic day that brings together cardiovascular testing, metabolic assessment, imaging, and laboratory work that would normally require months of specialist appointments spread across different providers. Everything happens in one place, under one protocol, reviewed by one physician who understands the full picture.
The data from that day becomes the foundation for a personalised prevention plan. Not a generic recommendation. Not a wellness app. A specific set of actions, prioritised by actual risk, discussed with a physician who has seen your imaging, your blood work, your fitness metrics and your medical history all at once.
For companies whose leadership teams and high performers are sitting on undetected risks, this changes the conversation from “we offer health benefits” to “we actually know where we stand and what we need to do about it.”
More importantly, it changes retention. Employees who feel genuinely looked after, not just covered but understood, stay longer and perform better. The executives who have a clear picture of their own health risks make better decisions about how they work, how they rest, and how they lead.
Prevention as a Strategic Investment
The leaders who are early to this shift are not doing it as an employee perk. They are doing it as a business strategy, and treating it accordingly.
Investing in evidence-based preventive health improves productivity, supports retention, and builds the kind of organisational resilience that compounds over time. But the programmes must demonstrate real value. A checkbox exercise that produces a data printout with no meaningful interpretation is not prevention. It is noise.
What actually moves the needle is physician-led assessment, a clear prevention plan with prioritised actions, and a structure for following up over time. YEARS builds this into the model. The initial diagnostic day is followed by a detailed results consultation, usually within a week. For the Evolve and Ultimate programmes, clients receive follow-up check-ins at regular intervals, with at-home blood testing and video consultations with their physician. The data becomes a trajectory, not a snapshot.
That is the standard that forward-thinking companies are beginning to demand. And it is the standard that is quietly separating the organisations treating health as a cost centre from the ones treating it as a competitive advantage.
The Shift Is Already Happening
The question for any leader reading this is not whether the shift toward preventive health is coming. It is whether your organisation is part of it, or waiting until the costs of not acting become impossible to ignore.
Most chronic conditions that shorten careers and drain organisational performance develop silently, years before they produce symptoms. The window for intervention is real, but it is finite. Waiting for a diagnosis is not a strategy. It is a choice, and one that carries a growing cost as the evidence for preventive medicine continues to build.
The companies building genuine health strategies now are the ones that will look back in five years and recognise this as one of the most important decisions they made.
For organisations interested in exploring what modern corporate prevention looks like, YEARS offers a free consultation to discuss how a structured health programme might fit your company’s needs. More information is available at www.years.co/en/corporate.
—
